by Devices and Pharma | Oct 27, 2026 | Cardiovascular, Device Warning Letters, Industry Information, Industry News, Inspections, Med-Devices, Products_Devices, QMSR, Quality Management System, US-FDA
Medical Device Warning Letter to Peter Schiff Enterprises Quality system violations dating back to 2011 Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact Agency cites device classification disputes, inadequate...
by Devices and Pharma | Oct 27, 2026 | Biologics Warning Letters, Biologics-information, Stem Cells, US-FDA
Biologics Warning Letters Unapproved stem cell and placenta products Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact FDA challenges claims that biological products can treat serious diseases without...
by Devices and Pharma | Oct 27, 2026 | Biologics Warning Letters, Biologics-information, Industry Information, Industry News, US-FDA
Biologics Warning Letters Claimed device classification not supported by intended use Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact FDA’s warning letter to Tides Medical illustrates how a...
by Devices and Pharma | Jul 29, 2026 | Drug Warning Letters, Veterinary, Warning Letter
Veterinary Warning Letters Violations of Pharma CGMP Regulations Home Industry Veterinary Devices Orthopedics Drugs Biologics FAQs News Contact Us FDA Warning Letter to AHC Products, Inc. for CGMP Violations The U.S. Food and Drug Administration (FDA) has issued a...
by Devices and Pharma | Jul 11, 2026 | Drug Warning Letters, Industry Information, Industry News, Ketamine, Pharmaceuticals, Products_Drugs, US-FDA
FDA Warning Letters Coordinated enforcement for online ketamine sales Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News...
by Devices and Pharma | Jun 24, 2026 | Consumer Information, Drug Warning Letters, Industry Information, Industry News, Pharmaceutical Labeling, Products_Drugs, Unapproved Drugs, US-FDA
FDA Warning Letters Wild Arabic Herbs “Edral-17t” product an unapproved new drug Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central...
